Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of California, San Francisco
The proposed study strives to demonstrate the non-inferiority of using MydCombi to achieve pupillary dilation in patients compared to standard-of-care (SOC) eye drops in a randomized trial.
Primary Aim: Demonstrate non-inferiority of using MydCombi to achieve pupillary dilation compared to standard-of-care eye drops in patients.
Participants 2 years or older undergoing standard pupillary dilation will be randomized to use MydCombi in one eye and standard of care pupillary dilation in another eye.
Age
2–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Receiving pupillary dilation in both eyes as part of the participant's standard of care.
You may not be if
Pupillary or anterior segment abnormality
Participants with pre-existing health conditions that would prevent pupillary dilation.
